PIK3CA and head and neck squamous cell carcinoma: Thus, these findings will have significant clinical implications, as they define a new mechanism-based precision therapeutic approach for the treatment of HNSCC patients, and define PIK3CA as a suitable biomarker of heightened beneficial therapeutic response to the combined treatment.